Log in to save to my catalogue

Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte...

Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ded2baee8a8442bbe3818bce0ec857c

Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre‐B acute lymphoblastic leukemia

About this item

Full title

Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre‐B acute lymphoblastic leukemia

Publisher

United States: John Wiley & Sons, Inc

Journal title

EJHaem, 2024-06, Vol.5 (3), p.620-623

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

This case report presents the successful management of relapsed/refractory (r/r) B‐cell acute lymphoblastic leukemia in a 54‐year‐old male post‐allogeneic hematopoietic cell transplantation. The combinatorial approach of sequential antibody treatment (Inotuzumab [InO] and Blinatumomab [Blina]) combined with three donor lymphocyte infusions (DLI) ap...

Alternative Titles

Full title

Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre‐B acute lymphoblastic leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5ded2baee8a8442bbe3818bce0ec857c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ded2baee8a8442bbe3818bce0ec857c

Other Identifiers

ISSN

2688-6146

E-ISSN

2688-6146

DOI

10.1002/jha2.927

How to access this item